Neonatal reflex in detail notes for pediatrics

Reading File

Finding Sources

Searching PubMed

newborn AND primitive reflexes

Searching the Web

newborn infant primitive reflexes Moro rooting sucking grasping stepping clinical examination Merck Manual

Reading File

Finding Sources

Reading Web Page

https://www.merckmanuals.com/professional/pediatrics/care-of…

Reading File

Finding Sources

Reading File

Neonatal Reflexes - Pediatrics Notes

Definition

Neonatal reflexes, also called primitive reflexes, are automatic, stereotyped motor responses present at birth or during early infancy. They arise mainly from the brainstem and spinal cord. Their presence, strength, symmetry, and timely disappearance help assess neurologic maturation and integrity of the central and peripheral nervous system.

A term newborn should have flexed posture, good tone, and symmetric spontaneous movements. Absent reflexes, marked asymmetry, or persistence beyond the expected age may indicate neurologic disease. Textbook of Family Medicine, 9e, p. 532.

Classification

1. Primitive reflexes

Present in fetal life or at birth and normally inhibited as cortical control develops.

Rooting
Sucking
Swallowing
Moro
Palmar and plantar grasp
Asymmetric tonic neck reflex
Stepping
Galant
Babinski response

2. Protective reflexes

Appear later and persist, because they protect the child from injury.

Parachute reflex
Blink reflex
Cough, sneeze, gag reflexes

Important examination principles

Examine the infant when awake, calm, warm, and preferably between feeds.
Interpret reflexes according to gestational age, especially in preterm infants.
Compare right and left sides.
Observe tone, posture, alertness, cranial nerves, spontaneous movement, and deep tendon reflexes alongside primitive reflexes.
Do not interpret one abnormal reflex alone without the clinical context.

The newborn neurologic examination includes assessment of state, posture, tone, spontaneous movements, and primitive reflexes. Textbook of Family Medicine, 9e, p. 532.

Primitive Neonatal Reflexes

Reflex	How to elicit	Normal response	Onset / presence	Disappearance
Rooting	Stroke cheek or corner of mouth	Turns head toward stimulus and opens mouth	Present at birth	3-4 months
Sucking	Put clean gloved finger or nipple in mouth	Rhythmic sucking	Present at birth	Becomes voluntary by 3-4 months
Swallowing	Milk/fluid reaches posterior pharynx	Coordinated swallowing	Present at birth	Persists
Moro	Sudden head drop/startle	Abduction-extension of arms, open hands, then adduction-flexion; cry	Present at birth	4-6 months
Palmar grasp	Press finger into palm from ulnar side	Flexion of fingers around examiner's finger	Present at birth	3-4 months
Plantar grasp	Press thumb at base of toes	Toe flexion	Present at birth	9-12 months
Asymmetric tonic neck reflex	Turn head to one side	Face-side limbs extend; opposite limbs flex	Present at birth	4-6 months
Stepping	Hold upright with soles on flat surface	Alternating stepping movements	Present at birth	1-2 months
Galant	Stroke paravertebral area	Lateral flexion of trunk toward stimulated side	Present at birth	2-4 months
Babinski	Stroke lateral sole from heel to forefoot	Great toe dorsiflexion with fanning of other toes	Normal in infants	12-24 months
Parachute	Suspend infant vertically, tilt forward	Arms extend forward as if to break fall	7-9 months	Persists for life

Textbook of Family Medicine, 9e, p. 533. Some age ranges vary modestly among references and should be treated as approximate clinical milestones.

1. Rooting reflex

Method

Stroke the cheek, lateral lip, or skin near the angle of the mouth.

Normal response

The infant turns the head toward the stimulated side, opens the mouth, and attempts to latch.

Function

Helps the newborn locate the nipple for feeding.

Clinical significance

Absent or weak reflex: prematurity, CNS depression, severe illness, sedative or maternal drug exposure, neurologic dysfunction.
Persistence after 4-6 months: may suggest delayed cortical maturation or cerebral palsy.
May be reduced immediately after a feed because the infant is satiated.

Merck describes rooting as head-turning and mouth opening after stimulation of the cheek or lateral lip, and identifies it as part of the routine newborn neurologic examination in its professional newborn examination guide.

2. Sucking reflex

Method

Place a gloved little finger, nipple, or pacifier in the infant's mouth.

Normal response

Rhythmic sucking movements occur.

Function

Essential for oral feeding. Effective feeding also requires coordinated suck-swallow-breathe activity.

Clinical significance

Absent or poor suck may occur with prematurity, hypoxia, sepsis, intracranial pathology, neuromuscular disease, congenital anomalies of the mouth, or CNS-depressant medication exposure.
Poor coordination with swallowing may lead to choking, coughing, cyanosis, or aspiration during feeds.
In preterm babies, suck may be weak or uncoordinated because the reflex and coordination mature late in gestation.

3. Swallowing reflex

Method

Occurs when milk or fluid reaches the pharynx.

Normal response

Pharyngeal contraction and swallowing occur with coordinated airway protection.

Function

Allows safe transfer of milk from mouth to esophagus.

Clinical significance

A poor suck-swallow-breathe sequence can indicate prematurity, neurologic impairment, bulbar dysfunction, or systemic illness. It requires prompt feeding assessment if aspiration is suspected.

4. Moro reflex or startle reflex

Method

Support the infant in a semi-reclining or supine position. Allow the head and trunk to fall back slightly and suddenly while continuing to support the infant. A loud sound may also elicit it.

Do not allow the head to strike the surface.

Normal response: two phases

First phase: sudden symmetric abduction and extension of both arms, with opening of fingers.
Second phase: adduction and flexion of arms toward the body, often followed by crying.

The typical response is arm extension with fingers extended, hip flexion, and crying after a sudden release or startle stimulus, as described in the Merck newborn examination reference.

Age

Appears: approximately 28 weeks' gestation
Fully developed: term infant
Disappears: 4-6 months

Clinical significance

Absent bilateral Moro

Consider:

Severe CNS depression
Severe hypoxic-ischemic encephalopathy
Intracranial hemorrhage
Sedative, opioid, or anesthetic drug exposure
Severe hypotonia
Prematurity, if not yet developmentally expected

Asymmetric Moro

Very important finding. Causes include:

Clavicle fracture
Brachial plexus injury, especially Erb palsy
Humerus fracture
Hemiplegia or focal neurologic lesion
Painful arm movement due to local trauma

In brachial plexus injury, the Moro reflex may be asymmetric, and lower-root involvement can also cause an absent grasp reflex. Bradley and Daroff's Neurology in Clinical Practice, section “Brachial Plexus Injury.”

Persistent Moro after 6 months

May suggest:

Cerebral palsy
Diffuse brain injury
Delayed cortical maturation

5. Palmar grasp reflex

Method

Place the examiner's finger in the infant's palm and apply gentle pressure.

Normal response

The fingers flex and grasp the examiner's finger.

Age

Appears: around 28 weeks' gestation
Present at birth
Disappears: 3-4 months

Clinical significance

Absent or asymmetric response may indicate peripheral nerve injury, brachial plexus lesion, spinal cord lesion, or focal CNS pathology.
Persistence beyond 4-6 months can be associated with cerebral palsy or upper motor neuron dysfunction.
Absence of grasp on the affected side with lower brachial plexus injury suggests involvement of C8-T1 roots.

6. Plantar grasp reflex

Method

Press gently just proximal to the toes on the sole of the foot.

Normal response

The toes flex around the examiner's finger.

Age

Present at birth
Disappears: approximately 9-12 months

Clinical significance

Persistence may delay independent walking because the toes continue to flex when the sole touches the ground.

7. Asymmetric tonic neck reflex, ATNR

Other name

Fencing posture reflex

Method

Place the calm infant supine and turn the head gently to one side.

Normal response

Arm and leg on the side to which the face is turned: extension
Arm and leg on the opposite side: flexion

Example: Head turned right produces extension of the right limbs and flexion of the left limbs.

Age

Appears: during late fetal period
Present at birth
Disappears: about 4-6 months

Function

May assist early hand-eye coordination and development of midline control.

Clinical significance

An exaggerated, obligatory, or persistent ATNR may interfere with rolling, bringing hands to midline, and bilateral hand use.
Persistence beyond 6 months suggests delayed neurologic maturation or cerebral palsy.
It may be less easily elicited in a crying or tense infant.

Textbook of Family Medicine, 9e, p. 533: head turning causes extension of the face-side upper and lower limbs with flexion of the contralateral limbs.

8. Stepping reflex

Method

Hold the infant upright under the arms with the trunk supported. Allow the soles to touch a firm flat surface.

Normal response

The infant makes alternating, reciprocal stepping-like movements.

Age

Present at birth
Usually disappears by 1-2 months

Clinical significance

Its early disappearance is normal and does not predict inability to walk.
Voluntary walking later emerges at about 9-15 months after maturation of postural control, balance, strength, and cortical motor function.
Absence may be seen in severe hypotonia, weakness, or neuromuscular disorder, but it should not be assessed in isolation.

9. Galant reflex

Method

Hold the infant prone or in ventral suspension. Stroke one side of the paravertebral area from shoulder toward buttock.

Normal response

The trunk curves laterally toward the side of stimulation. The ipsilateral hip may move outward.

Age

Present at birth
Disappears by about 2-4 months

Clinical significance

Asymmetry can occur with spinal lesions, peripheral nerve injury, or asymmetry of trunk musculature.
Persistence beyond expected age may be associated with neurologic dysfunction.
It is sometimes discussed in relation to scoliosis screening, but it is not independently diagnostic of scoliosis.

10. Babinski response

Method

Stroke the lateral border of the sole from heel upward, then across the forefoot medially.

Normal response in infants

Dorsiflexion of the great toe
Fanning of the other toes

Age

An extensor plantar response is physiologic in infancy because corticospinal tracts are incompletely myelinated. It may remain normal until 12-24 months.

Clinical significance

In older children and adults, an extensor plantar response suggests upper motor neuron dysfunction.
In an infant, it should not alone be considered pathologic.
A consistently asymmetric response requires neurologic assessment in the appropriate clinical context.

The Harriet Lane Handbook, 23e, p. 725 notes that an upgoing Babinski response is expected in infants until approximately 1-2 years of age.

Protective and other reflexes

11. Parachute reflex

Method

Hold the infant in vertical suspension and tilt forward rapidly toward a surface.

Normal response

The infant extends both arms and opens the hands as though attempting to protect against a fall.

Age

Appears: approximately 7-9 months
Persists throughout life

Clinical significance

Absence after the age when it should be established may indicate motor delay, cerebral palsy, or significant neurologic impairment. The Harriet Lane Handbook, 23e, p. 725.

12. Blink reflex

Method

Expose the infant to bright light, sudden visual threat, or a puff of air near the eye.

Normal response

Eyelid closure.

Significance

It is protective and persists throughout life. Absence may indicate severe visual impairment, facial nerve dysfunction, or depressed consciousness.

13. Gag reflex

Method

Stimulation of posterior pharynx.

Normal response

Pharyngeal contraction, retching, or gagging.

Significance

Protects the airway. A weak or absent gag reflex can occur with bulbar dysfunction or severe neurologic impairment, but gag testing should be gentle and is not routinely necessary in every healthy newborn.

Clinical interpretation of abnormal neonatal reflexes

A. Reflex absent or weak

Possible causes:

Prematurity
Severe birth asphyxia or hypoxic-ischemic encephalopathy
Intracranial hemorrhage
CNS infection
Sepsis or severe systemic illness
Drug-induced CNS depression
Severe hypotonia
Neuromuscular disorders
Peripheral nerve or brachial plexus injury

B. Reflex asymmetric

Think of a localized lesion or injury.

Abnormality	Important possibilities
Asymmetric Moro	Clavicle fracture, humerus fracture, brachial plexus injury, hemiplegia
Asymmetric palmar grasp	Lower brachial plexus injury, peripheral nerve lesion, focal CNS lesion
Asymmetric Galant	Spinal or peripheral nerve lesion, asymmetric trunk pathology
Decreased movement of one arm plus asymmetric Moro	Erb palsy or painful clavicle fracture until proved otherwise

C. Reflex exaggerated

May be seen with:

Hyperexcitability
Drug withdrawal, including neonatal abstinence syndrome
Hypertonia
Early neurologic irritation

D. Reflex persists beyond expected age

Persistence indicates inadequate suppression of lower-level reflex activity by developing cortical pathways. It may be associated with:

Cerebral palsy
Global developmental delay
Diffuse CNS injury
Severe intellectual or motor impairment

Persistent primitive reflexes alone do not establish a diagnosis. They should be interpreted with developmental milestones, tone, posture, motor symmetry, head growth, and feeding ability.

High-yield viva points

Moro reflex is absent or asymmetric in clavicle fracture and brachial plexus palsy.
Rooting and sucking are feeding reflexes.
ATNR is the fencing reflex.
Stepping reflex disappears early, at around 1-2 months.
Babinski is normal in infants up to about 1-2 years.
Parachute appears later, around 7-9 months, and persists for life.
Primitive reflex persistence suggests delayed cortical maturation or CNS pathology.
Preterm infants may have incompletely developed reflexes, so assess by corrected gestational age.
A normal Moro must be symmetric.
Primitive reflexes are part of neurologic examination, not a substitute for assessing tone and spontaneous movement.

Quick mnemonic: “Moro Roots for a Grasping Fencer who Steps”

Moro: 4-6 months
Rooting: 3-4 months
Grasp, palmar: 3-4 months
Fencing, ATNR: 4-6 months
Stepping: 1-2 months

A practical current reference table gives Moro disappearance by 6 months, stepping by 3-4 months, rooting/sucking by 3-4 months, and Babinski by 9-12 months, illustrating that exact ranges vary somewhat by source and method of assessment. See the Queensland Health reflex summary.

National immunization program

Reading File

Which country’s National Immunization Programme do you need?

India - Universal Immunization Programme (UIP)
Nepal
Bangladesh
Pakistan
Other country

India

Searching the Web

site:mohfw.gov.in National Immunization Schedule India UIP 2025 2026 pdf vaccines age schedule

Searching the Web

site:nhm.gov.in National Immunization Schedule India UIP 2025

Finding Sources

Searching PubMed

India AND immunization program

Reading Web Page

https://mohfw.gov.in/sites/default/files/2454535210614896638…

Reading File

Finding Sources

Searching the Web

India current National Immunization Schedule 2025 2026 Td pregnant women PCV schedule MR JE UIP pdf

National Immunization Programme, India

Universal Immunization Programme (UIP)

The Universal Immunization Programme (UIP) is the Government of India’s free routine immunization programme for all pregnant women and children. It is implemented through the National Health Mission and aims to reduce morbidity, mortality, and disability from vaccine-preventable diseases.

India started the Expanded Programme on Immunization (EPI) in 1978. It was expanded and renamed the Universal Immunization Programme (UIP) in 1985, initially focusing on children younger than 1 year. Park’s Textbook of Preventive and Social Medicine, section “Universal Immunization Programme.”

Diseases covered under UIP

UIP protects against the following major vaccine-preventable diseases:

Tuberculosis
Hepatitis B
Poliomyelitis
Diphtheria
Pertussis
Tetanus
Haemophilus influenzae type b disease
Measles
Rubella
Rotavirus diarrhoea
Pneumococcal disease
Japanese encephalitis in endemic districts only

The Ministry of Health and Family Welfare describes UIP as a centrally funded, ongoing programme for children and pregnant women in its UIP programme overview.

National Immunization Schedule, India

A. Schedule for infants and children

Age	Vaccine
At birth	BCG, Hepatitis B birth dose, OPV-0
6 weeks	OPV-1, Pentavalent-1, fIPV-1, Rotavirus-1, PCV-1
10 weeks	OPV-2, Pentavalent-2, Rotavirus-2
14 weeks	OPV-3, Pentavalent-3, fIPV-2, Rotavirus-3, PCV-2
9-12 months	MR-1, fIPV-3, PCV booster, Vitamin A first dose, JE-1 in endemic districts
16-24 months	DPT booster-1, OPV booster, MR-2, JE-2 in endemic districts, Vitamin A second dose
2-5 years	Vitamin A every 6 months, from dose 3 to dose 9
5-6 years	DPT booster-2
10 years	Td
16 years	Td

This schedule is consistent with the UNICEF India immunization schedule and current state NHM schedule summaries.

B. Schedule for pregnant women

Vaccine	Timing	Dose, route, site
Td-1	As early as possible in pregnancy	0.5 mL IM, upper arm
Td-2	4 weeks after Td-1	0.5 mL IM, upper arm
Td booster	If the woman received 2 doses of Td/TT in a previous pregnancy within the last 3 years	0.5 mL IM, upper arm

Td-2 or the booster is preferably administered before 36 weeks of pregnancy, but should still be given later if missed.

Vaccine-wise notes

1. BCG

Disease prevented: Severe childhood tuberculosis, especially tuberculous meningitis and miliary TB.
When: At birth or as early as possible, up to 1 year of age.
Dose:
- 0.05 mL in infants younger than 1 month
- 0.1 mL from 1 month onward
Route: Intradermal
Site: Left upper arm
Normal local reaction: Papule, ulcer, then scar formation.

2. Hepatitis B birth dose

When: At birth, preferably within 24 hours.
Dose: 0.5 mL
Route: Intramuscular
Site: Anterolateral mid-thigh.
The birth dose prevents perinatal and early horizontal transmission of hepatitis B.

3. Oral polio vaccine, bOPV

OPV-0: At birth, as early as possible, usually within first 15 days.
OPV-1, 2, 3: At 6, 10, and 14 weeks.
OPV booster: At 16-24 months.
Dose: 2 drops orally.

India was certified polio-free in 2014, but continued routine OPV/IPV and surveillance are essential to prevent re-establishment of poliovirus transmission. The MoHFW polio programme summary describes the role of UIP, Pulse Polio campaigns, AFP surveillance, and environmental surveillance.

4. Fractional inactivated polio vaccine, fIPV

Schedule: 6 weeks, 14 weeks, and 9-12 months.
Dose: 0.1 mL
Route: Intradermal
Site: Right upper arm.
fIPV induces strong systemic immunity and complements OPV.

5. Pentavalent vaccine

Components

Pentavalent vaccine protects against:

Diphtheria
Pertussis
Tetanus
Hepatitis B
Hib disease

Schedule

6 weeks: Pentavalent-1
10 weeks: Pentavalent-2
14 weeks: Pentavalent-3

Administration

Dose: 0.5 mL
Route: Intramuscular
Site: Anterolateral thigh.

6. Rotavirus vaccine

Purpose: Prevents severe rotavirus diarrhoea and dehydration.
Schedule: 6, 10, and 14 weeks.
Route: Oral.
Should be given along with pentavalent doses.

7. Pneumococcal conjugate vaccine, PCV

Purpose: Prevents invasive pneumococcal disease, pneumonia, meningitis, and otitis media.
Schedule:
- PCV-1 at 6 weeks
- PCV-2 at 14 weeks
- PCV booster at 9-12 months
Dose: 0.5 mL
Route: Intramuscular
Site: Anterolateral thigh.

8. Measles-Rubella vaccine, MR

MR-1: 9-12 months
MR-2: 16-24 months
Dose: 0.5 mL
Route: Subcutaneous
Site: Right upper arm.

9. Japanese encephalitis vaccine

Given only in JE-endemic districts.
JE-1: 9-12 months
JE-2: 16-24 months
Dose: 0.5 mL
Route: Usually subcutaneous
Site: Left upper arm.

10. DPT booster doses

DPT booster-1: 16-24 months
DPT booster-2: 5-6 years
Dose: 0.5 mL
Route: Intramuscular.

11. Td vaccine

At 10 years: One dose
At 16 years: One dose
Dose: 0.5 mL IM in upper arm.
Td contains tetanus toxoid plus reduced-dose diphtheria toxoid.

12. Vitamin A supplementation

Although not a vaccine, it is delivered with the immunization programme.

First dose: 9 completed months with MR-1
- Dose: 1 lakh IU orally
Second dose: 16-18 months
- Dose: 2 lakh IU orally
Subsequent doses: Every 6 months until 5 years of age, for a total of 9 doses.

Important milestones in India

Year	Milestone
1962	BCG introduced under National Tuberculosis Programme
1978	Expanded Programme on Immunization launched
1985	UIP launched; measles added
1990	Vitamin A supplementation introduced
1995	Pulse Polio Immunization began
2002	Hepatitis B introduced in selected districts
2005	Auto-disable syringes introduced in UIP
2006	JE vaccine introduced in endemic areas
2011	Pentavalent vaccine introduced in selected states
2015	IPV introduced
2016	Rotavirus vaccine introduced
2017 onward	MR and PCV progressively expanded

Park’s Textbook of Preventive and Social Medicine, section “Universal Immunization Programme.”

Related UIP initiatives

Mission Indradhanush

Launched in 2014 to improve immunization coverage among children and pregnant women who are partially immunized or unimmunized.

Goal

To reach children who miss routine immunization because of:

Migration
Remote or hard-to-reach residence
Urban slums
Poor awareness
Weak access to health services

“7 colours” of Indradhanush

The programme originally focused on protection against seven diseases:

Tuberculosis
Diphtheria
Pertussis
Tetanus
Polio
Measles
Hepatitis B

Subsequently, the scope expanded as newer UIP vaccines were introduced.

Intensified Mission Indradhanush

A targeted campaign approach to increase full immunization coverage in low-coverage districts and high-risk areas.

Pulse Polio Programme

Began in India in 1995.
Uses National Immunization Days and Sub-National Immunization Days.
Provides additional OPV doses to all eligible children, irrespective of routine immunization status.
Routine immunization must still continue even when Pulse Polio doses are received.

Cold chain

The cold chain is the system for storing and transporting vaccines at recommended temperatures from manufacturer to beneficiary.

Usual storage temperature

Most UIP vaccines are stored at +2°C to +8°C during routine storage and transport.

Heat-sensitive vaccines

These are usually placed in the colder part of the ice-lined refrigerator:

OPV
Measles/MR
BCG
JE vaccine
Rotavirus vaccine

Freeze-sensitive vaccines

These must never be frozen:

Pentavalent
DPT
Td
Hepatitis B
PCV
IPV

Vaccine vial monitor, VVM

A VVM is a heat-sensitive label on vaccine vials that indicates cumulative heat exposure.

Inner square lighter than outer circle: vaccine can be used.
Inner square same colour as or darker than outer circle: discard vaccine.

Adverse Events Following Immunization, AEFI

Definition

An AEFI is any untoward medical event that follows immunization and does not necessarily have a causal relationship with the vaccine.

Types

Vaccine product-related reaction
Vaccine quality defect-related reaction
Immunization error-related reaction
Immunization anxiety-related reaction
Coincidental event

Common minor AEFIs

Pain, redness, swelling at injection site
Mild fever
Irritability
Crying
Local induration

Serious AEFIs requiring urgent evaluation

Anaphylaxis
Convulsions
Encephalopathy
Hypotonic-hyporesponsive episode
Persistent inconsolable crying
Death or hospitalization temporally following vaccination

High-yield exam points

UIP started in 1985; EPI started in 1978.
Hepatitis B birth dose should be given within 24 hours.
Pentavalent vaccine is given at 6, 10, and 14 weeks.
fIPV is given at 6 weeks, 14 weeks, and 9-12 months.
PCV uses a 2 primary dose plus 1 booster schedule: 6 weeks, 14 weeks, and 9-12 months.
MR is given at 9-12 months and 16-24 months.
JE vaccine is given only in endemic districts.
DPT boosters are at 16-24 months and 5-6 years.
Td is given at 10 years and 16 years.
UIP provides vaccination free of cost at public health facilities.
Pulse Polio doses are additional and do not replace routine OPV/IPV doses.

Each vaccine in detail

Reading File

“Each vaccine in detail” under India’s UIP is a large topic. It includes:

BCG
Hepatitis B birth dose
Oral polio vaccine (bOPV)
Fractional IPV
Pentavalent vaccine
Rotavirus vaccine
Pneumococcal conjugate vaccine
Measles-Rubella vaccine
Japanese encephalitis vaccine
DPT boosters
Td for adolescents and pregnancy
Vitamin A supplementation, cold chain, contraindications, and AEFI

For each vaccine, the detailed note can cover: type/composition, disease prevented, schedule, dose, route, site, storage, contraindications, adverse effects, and key exam points.

Which section should I write in full first?

All

Reading File

A full detailed note on every UIP vaccine is best studied in sections. It covers:

Birth vaccines: BCG, hepatitis B birth dose, bOPV-0
Primary-series vaccines: bOPV, fIPV, pentavalent, rotavirus, PCV
Nine-month vaccines: MR, fIPV booster, PCV booster, JE in endemic districts
Booster and adolescent vaccines: DPT boosters, OPV booster, MR-2, Td
Maternal vaccination: Td in pregnancy
Practical immunization: dose, route, site, storage, VVM, open-vial policy, contraindications, AEFI, and catch-up principles

High-level overview: UIP uses live attenuated vaccines such as BCG, OPV, rotavirus, and MR; inactivated/toxoid vaccines such as IPV, PCV, DPT/pentavalent components, hepatitis B, and Td; and combination vaccines such as pentavalent. For exams, learn each under: type, disease prevented, schedule, dose, route/site, storage, adverse effects, contraindications, and key points.

Choose one section to start with, and I will provide full exam-oriented notes for it.

Create a complete vaccine-wise UIP study table

Searching the Web

India National Immunization Schedule UIP current 2026 vaccine dose route site fIPV PCV MR Td pregnant women official

Finding Sources

Searching PubMed

India AND immunization program

India UIP: Complete Vaccine-Wise Study Table

UIP = Universal Immunization Programme. It provides routine vaccines free of cost to children and pregnant women through public health facilities.

Important: The table follows the current National Immunization Schedule commonly used in India. Japanese encephalitis is only for notified endemic areas. Local programme instructions should be followed for vaccine brand-specific handling and administration.

1. Master UIP schedule

Age	Vaccines
At birth	BCG, Hepatitis B birth dose, bOPV-0
6 weeks	bOPV-1, Pentavalent-1, fIPV-1, Rotavirus-1, PCV-1
10 weeks	bOPV-2, Pentavalent-2, Rotavirus-2
14 weeks	bOPV-3, Pentavalent-3, fIPV-2, Rotavirus-3, PCV-2
9-12 months	MR-1, fIPV-3, PCV booster, Vitamin A first dose, JE-1 in endemic districts
16-24 months	DPT booster-1, bOPV booster, MR-2, JE-2 in endemic districts, Vitamin A second dose
2-5 years	Vitamin A doses 3-9, every 6 months
5-6 years	DPT booster-2
10 years	Td
16 years	Td
Pregnancy	Td-1, Td-2, or Td booster

This schedule is reflected in the Government NIS schedule and the UNICEF India schedule.

2. Vaccine-wise detailed study table

Vaccine	Type and contents	Diseases prevented	UIP schedule	Dose, route, site	Storage and key practical point
BCG	Live attenuated Mycobacterium bovis	Severe childhood TB, especially TB meningitis and miliary TB	At birth or as early as possible, up to 1 year	0.05 mL ID if age <1 month; 0.1 mL ID if ≥1 month. Left upper arm	2-8°C; protect from light. Reconstituted vaccine should be discarded within 4 hours or at session end.
Hepatitis B birth dose	Recombinant subunit vaccine containing hepatitis B surface antigen	Perinatal and childhood hepatitis B, chronic hepatitis, cirrhosis, hepatocellular carcinoma	Within 24 hours of birth, as early as possible	0.5 mL IM, anterolateral left thigh	Freeze-sensitive. Never freeze. Birth dose must not be delayed for low birth weight or prematurity.
bOPV	Live attenuated bivalent oral poliovirus vaccine, types 1 and 3	Poliomyelitis	OPV-0 at birth, then at 6, 10, 14 weeks; booster at 16-24 months	2 drops orally	Highly heat-sensitive. Keep frozen in long-term storage; maintain cold chain. OPV is given even if the child has mild diarrhoea.
fIPV	Fractional inactivated poliovirus vaccine	Poliomyelitis	6 weeks, 14 weeks, and 9-12 months	0.1 mL intradermal, right upper arm	Freeze-sensitive. Provides strong humoral immunity; used along with OPV, not as a replacement for it.
Pentavalent vaccine	Combination vaccine: DPT + hepatitis B + Hib	Diphtheria, pertussis, tetanus, hepatitis B, Hib meningitis/pneumonia	6, 10, 14 weeks	0.5 mL IM, anterolateral left thigh	Freeze-sensitive. Shake well before use. Contains whole-cell pertussis vaccine in UIP.
Rotavirus vaccine, RVV	Live attenuated oral rotavirus vaccine	Severe rotavirus gastroenteritis and dehydration	6, 10, 14 weeks	5 drops orally	Store at 2-8°C. Do not repeat a dose if child spits up or vomits immediately after vaccination.
PCV	Pneumococcal conjugate vaccine	Pneumococcal pneumonia, meningitis, sepsis, otitis media	6 weeks, 14 weeks, booster at 9-12 months	0.5 mL IM, anterolateral right thigh	Freeze-sensitive. Uses a 2 primary dose plus 1 booster schedule.
MR vaccine	Live attenuated measles and rubella viruses	Measles and congenital rubella syndrome	MR-1 at 9-12 months; MR-2 at 16-24 months	0.5 mL SC, right upper arm	Lyophilized, light-sensitive. Reconstituted vaccine must be used within 4 hours or discarded at end of session.
JE vaccine	Live attenuated or inactivated JE vaccine, depending on programme supply	Japanese encephalitis	JE-1 at 9-12 months; JE-2 at 16-24 months, only in endemic districts	0.5 mL. Route/site depend on product and local programme direction, commonly SC in upper arm for some formulations	Protect from light; follow district-specific product instructions.
DPT booster-1	Diphtheria, whole-cell pertussis, tetanus toxoids	Diphtheria, pertussis, tetanus	16-24 months	0.5 mL IM, anterolateral left thigh	Freeze-sensitive. First childhood booster.
DPT booster-2	Diphtheria, whole-cell pertussis, tetanus toxoids	Diphtheria, pertussis, tetanus	5-6 years	0.5 mL IM, upper arm	Freeze-sensitive. Completes early childhood DPT boosting.
Td	Tetanus toxoid plus reduced-dose diphtheria toxoid	Tetanus and diphtheria	10 years and 16 years	0.5 mL IM, upper arm	Freeze-sensitive. Td has replaced TT for adolescent and maternal immunization.
Td in pregnancy	Tetanus toxoid plus reduced-dose diphtheria toxoid	Maternal tetanus and neonatal tetanus, plus diphtheria protection	Td-1 early in pregnancy; Td-2 after 4 weeks; booster if 2 prior Td/TT doses received in last 3 years	0.5 mL IM, upper arm	Td-2 or booster preferably before 36 weeks, but give even if the woman presents later.

3. Important details for each vaccine

A. BCG vaccine

Point	Detail
Full form	Bacillus Calmette-Guérin vaccine
Type	Live attenuated bacterial vaccine
Main protection	Severe forms of childhood tuberculosis, especially TB meningitis and miliary TB
Timing	At birth or as early as possible up to 1 year
Dose	0.05 mL under 1 month; 0.1 mL from 1 month onward
Route/site	Intradermal, left upper arm
Normal reaction	Papule in 2-3 weeks, ulcer in 4-6 weeks, healing with scar by around 6-12 weeks
Common AEFI	Local ulcer, axillary lymphadenitis, abscess due to incorrect technique
Major contraindications	Known severe immunodeficiency, symptomatic HIV infection, severe acute illness temporarily
Exam point	BCG scar is evidence of successful local reaction, but absence of scar is not an indication for automatic revaccination.

B. Hepatitis B birth dose

Point	Detail
Type	Recombinant subunit vaccine
Antigen	Hepatitis B surface antigen, HBsAg
Main purpose	Prevents mother-to-child transmission and chronic hepatitis B infection
Timing	At birth, preferably within 24 hours
Dose	0.5 mL
Route/site	IM, anterolateral left thigh
Number of doses under UIP	Birth dose plus 3 hepatitis B-containing doses through pentavalent vaccine
Common AEFI	Local pain, fever, irritability
Contraindication	Anaphylaxis after a previous dose or to a vaccine component
Exam point	Give the birth dose even in preterm or low-birth-weight babies. Do not wait for the mother’s HBsAg report.

C. bOPV

Point	Detail
Full form	Bivalent oral polio vaccine
Type	Live attenuated oral vaccine
Strains	Poliovirus types 1 and 3
Schedule	Birth dose, 6, 10, 14 weeks, and booster at 16-24 months
Dose/route	2 drops orally
Main advantage	Produces intestinal immunity and reduces community transmission
Common AEFI	Usually none; extremely rare vaccine-associated paralytic poliomyelitis is associated with OPV
Contraindication	Known severe immunodeficiency is a relative concern for live OPV; follow national programme guidance
Exam point	OPV can be given with other vaccines and during minor illness or diarrhoea. Pulse Polio doses are additional and do not replace routine doses.

D. Fractional IPV

Point	Detail
Full form	Fractional inactivated poliovirus vaccine
Type	Inactivated killed poliovirus vaccine
Schedule	6 weeks, 14 weeks, and 9-12 months
Dose	0.1 mL
Route/site	Intradermal, right upper arm
Benefit	Strong systemic protection against paralytic polio
Common AEFI	Mild redness, swelling, or induration at injection site
Contraindication	Severe allergic reaction to previous IPV dose or components such as neomycin, streptomycin, or polymyxin B
Exam point	A small intradermal wheal should form after correct administration.

E. Pentavalent vaccine

Point	Detail
Type	Combination inactivated/toxoid vaccine
Components	Diphtheria toxoid, whole-cell pertussis, tetanus toxoid, hepatitis B antigen, Hib conjugate antigen
Diseases prevented	Diphtheria, pertussis, tetanus, hepatitis B, Hib pneumonia and meningitis
Schedule	6, 10, 14 weeks
Dose	0.5 mL
Route/site	IM, anterolateral left thigh
Common AEFI	Pain, redness, swelling, fever, crying, irritability
Rare serious AEFI	Persistent inconsolable crying, febrile seizure, hypotonic-hyporesponsive episode, anaphylaxis
Contraindication	Anaphylaxis after prior dose; encephalopathy within 7 days of a pertussis-containing vaccine without another explanation
Exam point	Pentavalent replaces separate DPT and hepatitis B primary-series doses. It does not replace the hepatitis B birth dose or DPT boosters.

F. Rotavirus vaccine

Point	Detail
Type	Live attenuated oral vaccine
Disease prevented	Severe rotavirus diarrhoea, dehydration, hospitalization
Schedule	6, 10, 14 weeks
Dose/route	5 drops orally
Common AEFI	Mild vomiting, loose stools, irritability
Rare serious AEFI	Intussusception is very rare
Contraindications	Previous intussusception, severe combined immunodeficiency, anaphylaxis to prior dose
Exam point	If the child vomits after administration, do not repeat the dose.

G. Pneumococcal conjugate vaccine

Point	Detail
Type	Polysaccharide antigens conjugated to a carrier protein
Diseases prevented	Pneumococcal pneumonia, meningitis, sepsis, otitis media
Schedule	6 weeks, 14 weeks, booster at 9-12 months
Dose	0.5 mL
Route/site	IM, anterolateral right thigh
Common AEFI	Pain, redness, swelling, fever, irritability
Contraindication	Anaphylaxis after prior PCV dose or to a component
Exam point	UIP PCV schedule is 2 primary doses + 1 booster, unlike a 3 primary dose schedule.

H. Measles-Rubella vaccine

Point	Detail
Type	Live attenuated viral vaccine
Diseases prevented	Measles, rubella, congenital rubella syndrome
Schedule	9-12 months and 16-24 months
Dose	0.5 mL
Route/site	Subcutaneous, right upper arm
Common AEFI	Fever, mild rash, lymphadenopathy
Important timing	Fever and rash may occur 5-12 days after vaccination
Contraindications	Pregnancy, severe immunodeficiency, previous anaphylaxis to vaccine components
Exam point	MR is a lyophilized vaccine. After reconstitution, it is light-sensitive and should be used within 4 hours or discarded at session end.

I. Japanese encephalitis vaccine

Point	Detail
Type	Depends on programme supply: live attenuated or inactivated vaccine
Disease prevented	Japanese encephalitis
Eligibility	Only children living in notified JE-endemic districts
Schedule	9-12 months and 16-24 months
Dose	Usually 0.5 mL
Route/site	Product-dependent. Follow current state/district programme instructions.
Common AEFI	Local pain, redness, mild fever
Contraindications	Severe allergic reaction to prior dose; defer in moderate or severe acute illness
Exam point	JE is not a universal vaccine for every district in India.

J. DPT boosters

Point	DPT booster-1	DPT booster-2
Schedule	16-24 months	5-6 years
Dose	0.5 mL	0.5 mL
Route	IM	IM
Site	Anterolateral left thigh	Upper arm
Diseases prevented	Diphtheria, pertussis, tetanus	Diphtheria, pertussis, tetanus
Common AEFI	Fever, local pain, swelling	Fever, local pain, swelling
Key point	Restores immunity after primary pentavalent series	Prepares for later adolescent Td doses

K. Td vaccine

Point	Detail
Full form	Tetanus and adult diphtheria vaccine
Type	Toxoid vaccine
Contents	Tetanus toxoid plus reduced-dose diphtheria toxoid
Schedule	10 years and 16 years
Dose	0.5 mL
Route/site	IM, upper arm
Common AEFI	Local pain, swelling, low-grade fever
Contraindication	Anaphylaxis after previous dose; defer in severe acute illness
Exam point	Td has replaced TT in the routine adolescent and pregnancy schedule because it protects against both tetanus and diphtheria.

L. Td in pregnancy

Vaccine	Timing	Dose and route
Td-1	As early as possible in pregnancy	0.5 mL IM, upper arm
Td-2	At least 4 weeks after Td-1	0.5 mL IM, upper arm
Td booster	If 2 prior Td/TT doses were received within the preceding 3 years	0.5 mL IM, upper arm

Purpose: Prevents maternal tetanus and neonatal tetanus through passive transfer of maternal antibodies to the fetus.

4. Vitamin A supplementation

Vitamin A is not a vaccine, but is delivered with the immunization programme.

Dose	Age	Amount
First dose	9 months with MR-1	1 lakh IU, oral, 1 mL
Second dose	16-18 months with MR-2	2 lakh IU, oral, 2 mL
Doses 3-9	Every 6 months up to 5 years	2 lakh IU, oral, 2 mL

Importance

Prevents xerophthalmia and nutritional blindness.
Reduces morbidity in vitamin A-deficient children.
Total: 9 doses by 5 years of age.

5. Vaccine storage: high-yield table

Heat-sensitive / light-sensitive	Freeze-sensitive
OPV	Hepatitis B
BCG	Pentavalent
MR	DPT
JE, depending on formulation	Td
Rotavirus vaccine	PCV
	IPV/fIPV

Vaccine vial monitor, VVM

Inner square lighter than outer circle: Use vaccine.
Inner square same colour as outer circle: Do not use.
Inner square darker than outer circle: Discard.

6. Open vial policy

Vaccines generally usable for up to 28 days after opening

Provided cold chain is maintained, expiry date has not passed, VVM is satisfactory, aseptic technique is followed, and vial is not contaminated:

OPV
Hepatitis B
Pentavalent
DPT
Td
PCV
IPV

Vaccines that must be discarded after 4 hours or at end of session after reconstitution

BCG
MR/measles-containing vaccine
Japanese encephalitis vaccine, if reconstituted

Park’s Textbook of Preventive and Social Medicine, section “Open Vial Policy.”

7. General contraindications and false contraindications

True contraindications

Situation	Relevant vaccines
Anaphylaxis after previous dose or a known vaccine component	All vaccines
Severe immunodeficiency	Live vaccines: BCG, OPV, MR, rotavirus, certain JE products
Pregnancy	Live MR vaccine
Encephalopathy within 7 days after previous pertussis-containing vaccine, with no alternative cause	Further pertussis-containing vaccine

False contraindications: vaccines should still be given

Mild fever, cough, cold, or diarrhoea
Malnutrition
Prematurity or low birth weight
Breastfeeding
Stable neurological disease
Family history of seizures
Antibiotic therapy
Convalescent phase of illness

8. One-line revision points

BCG: live vaccine, ID, left upper arm, scar forms.
Hepatitis B birth dose: within 24 hours of birth.
bOPV: 2 drops orally; birth, 6, 10, 14 weeks and booster.
fIPV: 0.1 mL ID, right upper arm, 6 weeks, 14 weeks, 9-12 months.
Pentavalent: DPT + Hep B + Hib, 6, 10, 14 weeks.
Rotavirus: oral vaccine at 6, 10, 14 weeks.
PCV: 6 weeks, 14 weeks, 9-12 months booster.
MR: 9-12 months and 16-24 months, SC right upper arm.
JE: only in endemic districts.
DPT boosters: 16-24 months and 5-6 years.
Td: 10 years, 16 years, and pregnancy.
Vitamin A: 9 doses up to 5 years, but it is not a vaccine.

A recent systematic review found that incomplete childhood immunization remains an important issue in India, emphasizing the importance of timely routine doses and follow-up of missed children (Gupta et al., 2026, PMID 42320383).

Vitamins and micronutrients deficiency in pediatrics with proper management and doses

This is a large pediatric nutrition topic. A complete note can be organized as:

Vitamin A deficiency: xerophthalmia, Bitot spots, keratomalacia, therapeutic and prophylactic dosing
Vitamin D deficiency: nutritional rickets, diagnosis, stoss versus daily treatment, calcium supplementation
Vitamin C deficiency: scurvy, management
Vitamin K deficiency: vitamin K deficiency bleeding, neonatal prophylaxis and treatment
B-complex deficiencies: thiamine, riboflavin, niacin, pyridoxine, folate, B12
Iron deficiency: anemia, oral iron treatment and prevention doses
Iodine deficiency: goiter, hypothyroidism, prevention
Zinc deficiency: diarrhea-related zinc treatment and nutritional deficiency
Calcium, phosphorus, magnesium, copper, selenium deficiencies
Protein-energy malnutrition and micronutrient supplementation in severe acute malnutrition

High-level overview

In pediatrics, the most clinically important deficiencies are vitamin A, vitamin D, iron, iodine, zinc, folate, and vitamin B12. Management requires three steps:

Confirm or strongly suspect the deficiency from history, examination, and appropriate tests.
Give an age- and severity-appropriate therapeutic dose, often with treatment of coexisting infection, malabsorption, or poor dietary intake.
Prevent recurrence with dietary counseling, supplementation where indicated, deworming when relevant, and follow-up for clinical and laboratory response.

Doses can differ substantially by age, body weight, severity, formulation, country programme, renal/hepatic disease, and whether the child has severe acute malnutrition. Therefore, treatment should be prescribed and monitored by a pediatric clinician, especially for vitamin A, vitamin D, iron, calcium, and injectable therapies.

Which section would you like in full detail first?

Create a complete pediatric micronutrient deficiency table

Reading File

A complete pediatric micronutrient deficiency table includes:

Fat-soluble vitamins: A, D, E, K
Water-soluble vitamins: B1, B2, B3, B6, B9, B12, C
Major minerals: iron, iodine, calcium, phosphorus, magnesium
Trace elements: zinc, copper, selenium, fluoride
Clinical application: key signs, diagnostic tests, treatment dose, duration, toxicity, dietary sources, prevention, and situations needing urgent referral

Overview: The highest-yield pediatric deficiencies are vitamin A, vitamin D, iron, iodine, zinc, folate, and vitamin B12. Management doses are clinically important and must be age- and formulation-specific. Severe disease, severe acute malnutrition, renal disease, malabsorption, cholestasis, or neurologic signs need pediatric supervision.

Which table should I create first?

A-D-E-K
B-complex and C
Iron, iodine, zinc
All minerals
One-page exam revision table

Create the complete micronutrient deficiency table now

Reading File

Finding Sources

Searching PubMed

pediatric micronutrient deficiency treatment

Searching the Web

pediatric micronutrient deficiency management treatment dose vitamin A D iron zinc WHO guideline children

A complete pediatric micronutrient deficiency table is best divided for accurate, safe dosing:

Fat-soluble vitamins: A, D, E, K
Water-soluble vitamins: B1, B2, B3, B6, folate, B12, C, biotin
Major minerals: iron, iodine, calcium, phosphorus, magnesium
Trace elements: zinc, copper, selenium, fluoride
Clinical management notes: confirmation tests, emergency features, therapeutic doses, duration, monitoring, toxicity, and prevention

High-yield overview: vitamin A, vitamin D, iron, zinc, iodine, folate, and B12 deficiencies are the priority conditions in pediatric practice. Doses require careful interpretation because they change with age, body weight, formulation, severity, renal/hepatic function, malabsorption, and severe acute malnutrition. Severe anemia, symptomatic hypocalcemia, keratomalacia, bleeding, seizures, or neurologic signs require urgent pediatric assessment.

Which part should I prepare as the detailed table first: vitamins, minerals, or the one-page exam revision table?

Create the complete table with pediatric treatment doses

Reading File

Finding Sources

Searching the Web

pediatric micronutrient deficiency treatment doses vitamin A vitamin D iron zinc folate B12 clinical guideline children

Searching PubMed

pediatric micronutrient deficiency treatment

Pediatric Micronutrient Deficiency: Complete Study Table With Treatment Doses

Clinical safety note: These are standard exam-oriented therapeutic regimens, not individualized prescriptions. Confirm the deficiency and identify the cause before treating. Doses vary in preterm infants, severe acute malnutrition, renal/hepatic disease, cholestasis, malabsorption, and genetic disorders. Urgent pediatric care is needed for keratomalacia, seizures/tetany, severe anemia, bleeding, heart failure, neuropathy, or suspected metabolic disease.

Always manage in 4 steps:

Confirm clinically and with appropriate tests.
Treat the deficiency.
Correct dietary cause, infection, malabsorption, blood loss, or drug cause.
Reassess clinical response and repeat relevant labs.

A. Fat-soluble vitamin deficiencies

Nutrient	Deficiency features	Key tests	Pediatric treatment dose	Duration and monitoring	Important cautions
Vitamin A	Night blindness, conjunctival xerosis, Bitot spots, corneal xerosis, keratomalacia, recurrent infections, poor growth	Serum retinol may support diagnosis but falls during infection; eye examination	Xerophthalmia/severe deficiency: orally on day 1, day 2, and day 14: <6 months: 50,000 IU each dose; 6-11 months: 100,000 IU each dose; ≥12 months: 200,000 IU each dose	Urgent ophthalmic assessment if corneal signs. Treat coexisting malnutrition, infection, diarrhea, and measles.	Do not use repeated high doses indiscriminately. Acute toxicity: headache, vomiting, irritability, bulging fontanelle. In severe anorexia, edema, septic shock, or malabsorption, route and dose require specialist advice.
Vitamin D	Rickets, delayed milestones, bone pain, wrist/ankle widening, bowed legs, genu valgum, delayed dentition, hypocalcemic seizures/tetany	Serum 25-OH vitamin D, calcium, phosphate, ALP, PTH; wrist radiograph if rickets suspected	Nutritional rickets: cholecalciferol/ergocalciferol 2,000 IU/day for infants <12 months; 3,000-6,000 IU/day for children >12 months, usually for 3 months. A supervised alternative is 50,000 IU weekly for 6 weeks in older children. Give elemental calcium at least 500 mg/day through diet or supplements during rickets treatment.	Recheck calcium, phosphate, ALP, and 25-OH D after about 3 months. Then give prevention dose, commonly 400 IU/day in infants and 600 IU/day after 1 year if intake/sun exposure is inadequate.	Do not use high-dose "stoss" therapy routinely without supervision. Hypercalcemia, hypercalciuria, nephrocalcinosis, and vomiting may signal toxicity. Evaluate non-nutritional rickets if response is poor.
Vitamin E	Hemolytic anemia in preterm infants, neuropathy, ataxia, reduced vibration sense, retinopathy, myopathy. Seen with fat malabsorption/cholestasis	Serum alpha-tocopherol, lipid profile, liver and malabsorption evaluation	Oral alpha-tocopherol 15-25 IU/kg/day is commonly used for deficiency due to malabsorption. Water-miscible formulations may be required in cholestasis.	Monitor serum vitamin E and neurologic/hematologic response.	Dose and formulation should be directed by a pediatric gastroenterologist in cholestasis or intestinal failure. High doses increase bleeding risk, particularly with vitamin K deficiency.
Vitamin K	Easy bruising, mucosal bleeding, GI bleeding, prolonged PT/INR; in infants, vitamin K deficiency bleeding can cause intracranial hemorrhage	PT/INR prolonged early; platelet count usually normal; evaluate liver disease and malabsorption	Non-bleeding deficiency: phytonadione often 1-5 mg orally or IV, according to age and severity. Active bleeding/VKDB: 1 mg IV slowly in neonates or young infants is commonly used, plus urgent correction with blood products when indicated.	Repeat PT/INR and investigate cause.	IV vitamin K can rarely cause anaphylactoid reactions. Active bleeding, altered sensorium, seizures, or bulging fontanelle requires emergency treatment. Newborn prophylaxis is separate: typically 1 mg IM at birth.

B. Water-soluble vitamin deficiencies

Nutrient	Deficiency features	Key tests	Pediatric treatment dose	Duration / management	Important cautions
Vitamin B1, thiamine	Infantile beriberi: tachycardia, cardiomegaly, heart failure, aphonia, irritability, lactic acidosis. Older child: neuropathy, weakness, Wernicke encephalopathy	Blood thiamine or erythrocyte transketolase if available; lactate; cardiac evaluation	Mild deficiency: 10-25 mg orally once daily. Symptomatic neurologic/cardiac disease: 10-25 mg IV or IM, then oral supplementation, under specialist care.	Usually continue oral treatment for at least 2-4 weeks while correcting diet. Give thiamine before glucose in suspected Wernicke encephalopathy.	Cardiac failure, acidosis, encephalopathy, or ophthalmoplegia are emergencies. Treat empirically if strongly suspected rather than waiting for results.
Vitamin B2, riboflavin	Angular cheilitis, cheilosis, stomatitis, glossitis, seborrheic dermatitis, corneal vascularization, anemia	Clinical diagnosis; assess other B-vitamin deficiencies	5-10 mg orally daily	Usually 2-4 weeks, with balanced diet and multivitamin support if multiple deficiencies are likely	Low toxicity. Look for malnutrition, malabsorption, and restrictive diet.
Vitamin B3, niacin	Pellagra: dermatitis, diarrhea, dementia. Photosensitive dermatitis, glossitis, irritability	Clinical diagnosis; assess dietary history, malabsorption, isoniazid exposure, Hartnup disease	Nicotinamide 50-300 mg/day orally, in divided doses. Use nicotinamide rather than nicotinic acid to avoid flushing.	Continue for 3-4 weeks and provide protein-rich diet plus B-complex supplementation.	Severe diarrhea, delirium, dehydration, or suspected Hartnup disease requires specialist review.
Vitamin B5, pantothenic acid	Very rare. Fatigue, irritability, paresthesias, dermatitis, enteritis	Usually clinical and dietary assessment	No standard isolated pediatric replacement regimen. Give balanced multivitamin and correct diet.	Reassess diet, malabsorption, and parenteral nutrition composition.	Isolated deficiency is uncommon. Search for another cause of symptoms.
Vitamin B6, pyridoxine	Seborrheic dermatitis, cheilosis, glossitis, irritability, peripheral neuropathy, seizures in severe deficiency, microcytic/sideroblastic anemia	CBC, smear; plasma pyridoxal phosphate if available; medication history, especially isoniazid	Nutritional deficiency: 5-25 mg orally daily. Suspected pyridoxine-dependent seizures require urgent specialist treatment, often with larger monitored doses.	Continue for 2-4 weeks, then dietary maintenance.	Chronic excessive pyridoxine can cause sensory neuropathy. Do not use high doses without supervision.
Vitamin B7, biotin	Dermatitis around mouth/eyes, alopecia, conjunctivitis, hypotonia, ataxia, seizures. Consider biotinidase deficiency	Biotinidase enzyme assay, metabolic tests when genetic disorder suspected	Nutritional deficiency: 5-10 mg orally daily is often used. Biotinidase deficiency: usually 5-20 mg/day lifelong, specialist-directed.	Clinical response may be rapid; genetic/metabolic evaluation is necessary if neurologic features occur.	Biotin can interfere with some laboratory immunoassays, including thyroid and troponin tests.
Vitamin B9, folate	Megaloblastic anemia, pallor, glossitis, poor growth, diarrhea. No neurologic deficits unless B12 also deficient	CBC, MCV, reticulocyte count, serum/RBC folate, B12 level	Folic acid 1 mg orally once daily	Usually for about 3-4 months or until hematologic recovery and dietary cause corrected	Measure or treat B12 deficiency first. Folate can correct anemia while allowing irreversible B12-related neurologic injury to progress.
Vitamin B12, cobalamin	Megaloblastic anemia, failure to thrive, hypotonia, developmental delay/regression, irritability, glossitis, neuropathy	CBC, smear, serum B12, methylmalonic acid, homocysteine; evaluate diet, intrinsic factor, ileal disease	Mild dietary deficiency: cyanocobalamin 100-1,000 micrograms orally daily. Symptomatic, severe, malabsorptive, or neurologic disease: hydroxocobalamin 1,000 micrograms IM using a pediatric hematology-directed loading schedule, then maintenance.	Monitor reticulocyte response in about 1 week, CBC, B12, neurologic recovery, and cause.	Neurologic signs require urgent treatment. Vegan breastfeeding mothers and breastfed infants may both require replacement.
Vitamin C, ascorbic acid	Scurvy: irritability, limb pain, refusal to walk, gingival bleeding/hypertrophy, petechiae, perifollicular hemorrhages, corkscrew hairs, poor wound healing	Plasma vitamin C if available; X-rays may show metaphyseal changes	100-300 mg orally daily, divided if needed	Continue for at least 1 month or until symptoms and diet normalize. Improvement in pain and general condition is often rapid.	Evaluate restrictive eating, autism-related food selectivity, neglect, malabsorption, and coexisting iron deficiency.

C. Major mineral deficiencies

Nutrient	Deficiency features	Key tests	Pediatric treatment dose	Duration / management	Important cautions
Iron	Pallor, fatigue, pica, poor appetite, irritability, developmental and cognitive effects, koilonychia. Severe anemia can cause tachycardia and heart failure	CBC, MCV, MCH, ferritin with CRP or other inflammation marker, reticulocyte count; evaluate blood loss, diet, parasites, malabsorption	Elemental iron 3-6 mg/kg/day orally in 1-2 doses for iron-deficiency anemia. A practical dose is often 3 mg/kg/day for mild-moderate anemia.	Hb should rise by about 1 g/dL after 2-4 weeks if diagnosis/adherence are correct. Continue treatment for at least 3 months after hemoglobin normalizes to replenish stores.	Dose refers to elemental iron, not ferrous sulfate salt. Avoid accidental overdose. IV iron or transfusion requires specialist indications.
Iodine	Goiter, impaired cognition, poor growth, hypothyroidism. In fetus/newborn, severe deficiency causes irreversible neurodevelopmental injury	Urinary iodine in population assessment; TSH and free T4 for individual thyroid dysfunction; thyroid examination	Usually managed by ensuring use of iodized salt rather than high-dose iodine. Recommended daily intake: 0-5 years 90 micrograms, 6-12 years 120 micrograms, adolescents 150 micrograms.	Treat hypothyroidism with levothyroxine, not iodine alone, if congenital or acquired hypothyroidism is present.	Do not give pharmacologic iodine empirically in children with goiter. Excess iodine can cause hypo- or hyperthyroidism. Refer for thyroid enlargement, abnormal TSH, nodules, or neonatal hypothyroidism.
Calcium	Tetany, paresthesia, muscle cramps, seizures, prolonged QT, rickets, poor bone mineralization	Ionized calcium or corrected calcium, phosphate, magnesium, ALP, PTH, 25-OH D, ECG	Chronic/asymptomatic deficiency: elemental calcium 30-75 mg/kg/day orally, divided. In nutritional rickets, at least 500 mg/day elemental calcium with vitamin D therapy.	Correct vitamin D deficiency, magnesium deficiency, renal disease, or hypoparathyroidism. Monitor calcium and urinary calcium where indicated.	Symptomatic hypocalcemia: 10% calcium gluconate 0.5-1 mL/kg IV slowly with ECG monitoring, in hospital. Extravasation can injure tissue.
Phosphorus	Rickets/osteomalacia, muscle weakness, bone pain, hemolysis, rhabdomyolysis, respiratory weakness in severe cases	Serum phosphate, calcium, ALP, PTH, renal function, urine phosphate; assess for renal tubular disorder	Mild dietary deficiency: increase dietary phosphate and treat cause. Significant hypophosphatemia generally requires specialist-directed oral phosphate, often 1-3 mmol/kg/day in divided doses.	Monitor phosphate, calcium, potassium, renal function, and urine calcium.	IV phosphate is high risk and requires hospital monitoring. Persistent hypophosphatemic rickets suggests renal phosphate wasting, not simple nutritional disease.
Magnesium	Tremor, tetany, seizures, weakness, arrhythmia, refractory hypokalemia or hypocalcemia	Serum magnesium, calcium, potassium, renal function, ECG if severe	Mild/asymptomatic: oral magnesium, often 0.2-0.4 mmol/kg per dose, 2-3 times daily, product-dependent.	Correct underlying GI loss, renal wasting, drug effect, or poor intake.	Symptomatic deficiency needs IV magnesium in hospital with monitoring. Dose must be adjusted in renal impairment.
Potassium	Weakness, ileus, polyuria, arrhythmias, ECG changes	Serum potassium, blood gas, magnesium, renal function, ECG	Potassium deficiency is usually treated according to serum level and ECG. Oral KCl is preferred if safe. Typical replacement is individualized, often 1-2 mmol/kg/day in divided doses for non-emergency deficits.	Identify GI loss, renal loss, diuretics, renal tubular acidosis, or refeeding syndrome.	IV potassium can cause fatal arrhythmias if given incorrectly. Never use IV potassium without monitored protocols.
Sodium	Poor growth, lethargy, vomiting, seizures in severe hyponatremia. Usually due to fluid imbalance rather than isolated dietary lack	Serum sodium, osmolality, glucose, urine sodium/osmolality, volume status	Treat the underlying fluid/electrolyte disorder, not "sodium deficiency" alone.	Rate of correction depends on acute versus chronic hyponatremia and symptoms.	Seizures or severe symptomatic hyponatremia require emergency hospital treatment with hypertonic saline protocols.

D. Trace element deficiencies

Nutrient	Deficiency features	Key tests	Pediatric treatment dose	Duration / management	Important cautions
Zinc	Growth faltering, anorexia, impaired wound healing, recurrent infections, dysgeusia, diarrhea, periorificial/acral dermatitis, alopecia. Severe inherited form: acrodermatitis enteropathica	Plasma/serum zinc, preferably fasting and away from acute inflammation; alkaline phosphatase may be low	Acquired nutritional deficiency: 0.5-1 mg/kg/day elemental zinc orally. Acrodermatitis enteropathica: 3 mg/kg/day elemental zinc orally, often lifelong. For acute diarrhea: <6 months 10 mg/day, ≥6 months 20 mg/day for 14 days.	Monitor growth, skin response, serum zinc if needed, and copper during prolonged high-dose therapy.	Zinc dose must be expressed as elemental zinc. Long-term excessive zinc can cause copper deficiency and anemia.
Copper	Anemia, neutropenia, hypopigmented hair, bone abnormalities, impaired immunity; Menkes disease causes hypotonia, seizures, kinky hair, neurodegeneration	Serum copper and ceruloplasmin, CBC, bone studies; genetic testing if Menkes suspected	Nutritional deficiency: usually 0.1-0.2 mg/kg/day elemental copper orally, specialist-directed. Menkes disease requires early parenteral copper therapy by metabolic specialists.	Recheck CBC, copper, ceruloplasmin, liver function, and cause.	Do not self-treat suspected Menkes disease. Copper can accumulate in cholestasis and liver disease.
Selenium	Rare in routine practice. Cardiomyopathy, myopathy, poor immunity, hair/nail changes, thyroid dysfunction, especially in long-term parenteral nutrition	Plasma selenium, glutathione peroxidase where available, thyroid tests, nutrition review	1-2 micrograms/kg/day orally or in parenteral nutrition is a commonly used replacement range, specialist-directed.	Monitor selenium level and clinical recovery.	Narrow safety margin. Excess causes hair/nail brittleness, GI symptoms, neuropathy, and garlic odor.
Fluoride	Increased dental caries risk, reduced enamel resistance	Dental assessment; community water fluoride history	Primary management is dental prevention: fluoride toothpaste appropriate for age, supervised brushing, dietary counseling. Professional fluoride varnish is usually 5% sodium fluoride applied by trained personnel.	Regular dental follow-up.	Do not prescribe systemic fluoride routinely without assessing water fluoride concentration. Excess causes dental/skeletal fluorosis.
Chromium	Extremely rare. Glucose intolerance, weight loss, peripheral neuropathy in prolonged unsupplemented parenteral nutrition	Plasma chromium is difficult to interpret; assess parenteral nutrition composition	Correct parenteral nutrition trace-element provision under specialist nutrition team guidance.	Treat underlying intestinal failure or PN formulation issue.	No standard oral pediatric deficiency regimen for routine use.
Manganese	Deficiency is exceptionally rare; may cause poor growth, dermatitis, impaired bone formation in long-term PN	Nutrition and PN review	Specialist adjustment of PN trace-element mixture.	Monitor especially in cholestasis because manganese toxicity is more common than deficiency.	Do not empirically give manganese supplements.
Molybdenum	Very rare; neurologic abnormalities in severe inherited cofactor deficiency	Metabolic testing	Requires metabolic specialist management.	Cause-specific management.	No routine empiric treatment dose.

E. High-yield emergency and referral table

Finding	Likely deficiency / concern	Immediate action
Corneal xerosis, corneal ulcer, keratomalacia	Severe vitamin A deficiency	Give age-appropriate vitamin A urgently and arrange ophthalmology review.
Seizure, carpopedal spasm, stridor, prolonged QT	Hypocalcemia, often due to vitamin D deficiency	Emergency assessment, ECG, serum calcium/magnesium/phosphate; IV calcium may be required.
Heart failure, lactic acidosis, aphonia in an infant	Thiamine deficiency, infantile beriberi	Give thiamine urgently and manage cardiac failure in hospital.
Severe pallor, tachycardia, respiratory distress, syncope	Severe anemia	Urgent CBC and pediatric assessment. Do not give transfusion solely from a table.
Bruising, GI bleeding, bleeding from injection sites, altered consciousness in young infant	Vitamin K deficiency bleeding	Emergency referral, vitamin K and blood-product management.
Developmental regression, hypotonia, neuropathy, macrocytosis	Vitamin B12 deficiency	Start urgent pediatric evaluation and B12 replacement.
Periorificial rash, alopecia, chronic diarrhea	Zinc deficiency or acrodermatitis enteropathica	Measure zinc and begin pediatric-supervised elemental zinc treatment.
Bone deformity or rickets not improving after vitamin D/calcium	Hypophosphatemic rickets, renal tubular disease, malabsorption, genetic rickets	Pediatric endocrinology/nephrology referral.

F. Pediatric treatment principles for common conditions

Condition	Standard first-line regimen
Iron-deficiency anemia	Elemental iron 3-6 mg/kg/day orally. Continue at least 3 months after Hb normalizes.
Nutritional rickets	Vitamin D 2,000 IU/day if <1 year, or 3,000-6,000 IU/day if >1 year, for around 3 months, plus at least 500 mg/day elemental calcium.
Xerophthalmia	Vitamin A on day 1, 2, and 14: 50,000 IU if <6 months, 100,000 IU at 6-11 months, 200,000 IU at ≥12 months.
Acute diarrhea	Zinc: <6 months 10 mg/day; ≥6 months 20 mg/day, orally for 14 days.
Scurvy	Vitamin C 100-300 mg/day orally for at least 1 month.
Folate deficiency	Folic acid 1 mg/day orally for 3-4 months, only after checking or covering vitamin B12 deficiency.
Dietary B12 deficiency	Oral cyanocobalamin 100-1,000 micrograms/day if mild and absorption intact; IM therapy for symptomatic, severe, or malabsorptive disease.
Hypocalcemic tetany	Hospital care: 10% calcium gluconate 0.5-1 mL/kg IV slowly with ECG monitoring, then identify and treat vitamin D, magnesium, or endocrine cause.

G. Dietary sources for prevention

Nutrient	Useful food sources
Vitamin A	Liver, egg yolk, milk, fortified foods; green leafy vegetables, carrots, pumpkin, mango, papaya
Vitamin D	Fortified milk/formula, egg yolk, oily fish, safe sun exposure
Iron	Meat, liver, eggs, legumes, lentils, green leafy vegetables, fortified cereals. Combine plant iron with vitamin C-rich foods.
Zinc	Meat, eggs, dairy, legumes, nuts, whole grains
Calcium	Milk, curd, paneer, ragi, sesame, fortified foods, green leafy vegetables
Folate	Green leafy vegetables, legumes, citrus fruits, fortified grains
Vitamin B12	Milk, eggs, meat, fish, fortified foods. Vegan children need a reliable supplement source.
Vitamin C	Citrus fruit, guava, amla, tomatoes, berries, peppers, potatoes
Iodine	Adequately iodized salt, seafood, dairy where available
Selenium	Fish, eggs, meat, cereals, nuts. Content varies by soil.

Key study cautions

Elemental iron, elemental calcium, and elemental zinc are not the same as the weight of the salt or syrup. Calculate from the product label.
Do not treat a child with macrocytosis using folate alone until vitamin B12 deficiency has been excluded or simultaneously treated.
In severe acute malnutrition, avoid routine early iron during initial stabilization. Correct hypoglycemia, hypothermia, infection, and electrolyte imbalance first.
Multiple deficiencies are common in restricted diets, malabsorption, inflammatory bowel disease, cystic fibrosis, chronic liver disease, kidney disease, and children receiving long-term parenteral nutrition.
The recent literature continues to identify iron, zinc, vitamin D, vitamin B12, folate, and fat-soluble vitamins among frequent pediatric deficiencies in chronic intestinal disease, supporting targeted testing rather than unsupervised broad high-dose supplementation, as reviewed in this pediatric IBD micronutrient review.

For broader clinical reference, the Royal Children’s Hospital micronutrient guideline provides formulation-specific advice and highlights when parenteral treatment or pediatric specialist consultation is needed.

This is a shared conversation. Sign in to Orris to start your own chat.